Mark James
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Pediatric health and respiratory diseases 1
- Co-authors
- Takeo Ishii (1 shared paper)Paul Jones (1 shared paper)Masaharu Nishimura (1 shared paper)A. A. Seawright (1 shared paper)Alicia J. Fraser (1 shared paper)P.J. O'Hara (1 shared paper)Danae Steele (1 shared paper)H. H. Draper (1 shared paper)
- Journals
- The Lancet (6 papers)Australian Veterinary Journal (1 paper)International Journal of COPD (1 paper)New Zealand Veterinary Journal (1 paper)
- Partner nations
- United KingdomAustraliaKenya
In The Last Decade
Mark James
10 papers receiving 1.6k citations
Mark James's Hit Papers
Peers
Comparison fields: 5 of 113
- Infectious Diseases 954
- Applied Microbiology and Biotechnology 50
- Neurology 339
- Internal Medicine 56
- Obstetrics and Gynecology 84
Countries citing papers authored by Mark James
This map shows the geographic impact of Mark James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark James more than expected).
Fields of papers citing papers by Mark James
This network shows the impact of papers produced by Mark James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark James. The network helps show where Mark James may publish in the future.
Co-authors
The 9 scholars most cited alongside Mark James, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2023 | 83 | |
| 7 | 2018 | 37 | |
| 8 | 1971 | 19 | |
| 9 | 1982 | 17 | |
| 10 | Tri-o-cresyl phosphate as a vitamin E antagonist in the lamb and rat. | 1952 | 3 |
About Mark James
Mark James is a scholar working on Infectious Diseases, Emergency Medical Services, Nephrology, Water Science and Technology and Physiology, having authored 10 papers that have together received 1.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Parathyroid Disorders and Treatments (1 paper), Pediatric health and respiratory diseases (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper), Plant Toxicity and Pharmacological Properties (1 paper), Asthma and respiratory diseases (1 paper) and Fluoride Effects and Removal (1 paper). The work is most often cited by research in Infectious Diseases (954 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (339 citations), Internal Medicine (56 citations) and Obstetrics and Gynecology (84 citations). Mark James has collaborated with scholars based in United Kingdom, Australia and Kenya. Frequent co-authors include Takeo Ishii, Paul Jones, Masaharu Nishimura, A. A. Seawright, Alicia J. Fraser, P.J. O'Hara, Danae Steele, H. H. Draper and B. Connor Johnson. Their work appears in journals such as The Lancet, Australian Veterinary Journal, International Journal of COPD and New Zealand Veterinary Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.